Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia. - Wikidata - awgldk - TriplyDB

Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia.

Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia.

http://www.wikidata.org/entity/Q44236057

about

Pharmacotherapies for sleep disturbances in Alzheimer's disease Melatonin for the treatment of dementia Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis Current treatments for sleep disturbances in individuals with dementia Circadian Rhythm Sleep Disorder: Irregular Sleep Wake Rhythm Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.The circadian clock and pathology of the ageing brain.Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value.Treatment of sleep disturbance in Alzheimer's dementia.The sleep-wake cycle and Alzheimer's disease: what do we know?Outpatient treatment of sleep disorders in Alzheimer patients Evaluation and management of the elderly patient presenting with cognitive complaints.Melatonin for sleep disorders and cognition in dementia: a meta-analysis of randomized controlled trials.Melatonin supplementation for severe and intractable sleep disturbance in young people with genetically determined developmental disabilities: short review and commentary Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials.Effect of home-based light treatment on persons with dementia and their caregivers.The human pineal gland and melatonin in aging and Alzheimer's disease.Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular S Meta-analysis of randomized, double-blind, placebo-controlled trials of melatonin in Alzheimer's disease.Melatonin Therapy in Patients with Alzheimer's Disease.Effect of morning bright light treatment for rest-activity disruption in institutionalized patients with severe Alzheimer's disease.Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease.Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease.Insomnia and dementia: is agomelatine treatment helpful? Case report and review of the literature.Optimizing the Pharmacologic Treatment of Insomnia: Current Status and Future Horizons New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists.A hypnic hypothesis of Alzheimer's disease.Melatonin reduces tachycardia in postural tachycardia syndrome: a randomized, crossover trial.The management of sleep and circadian disturbance in patients with dementia.Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.Recommendations of the Sleep Study Group of the Italian Dementia Research Association (SINDem) on clinical assessment and management of sleep disorders in individuals with mild cognitive impairment and dementia: a clinical review.Monoaminergic neuropathology in Alzheimer's disease.Melatonin for Sleep Disorders in Patients with Neurodegenerative Diseases.Treatment of Sleep Disorders in Dementia Pharmacotherapies for sleep disturbances in dementia.

P2860

Q24197895-CE386E89-3F06-48E0-B0C5-82713AE207F8 Q24244870-9102EC65-E547-423A-A5D1-62F204BA6A55 Q24537556-4F267F62-9B46-4188-A705-4EEA4BA805C8 Q24646671-2237DA26-D970-40FE-ABDA-FC43952E10C8 Q24648341-4293769A-1FA3-4292-8CF2-2F0219CF72EA Q24675909-B9DF1F40-9A23-4E5A-8759-915BA4363151 Q24675939-CBA8DD9F-5A2F-47D4-B3C5-9ED696B5B3D9 Q26772851-1ECA1797-F7F7-448C-8326-671091EC26E6 Q30405370-9197CC5D-306C-4E41-ABD8-271C688638F8 Q33800161-4F9B1BAB-0720-4755-8E5E-4DFFD95C7C52 Q34259247-38C340C6-BBFB-438F-94B6-C133043F37CD Q34358480-38EA00AE-AF17-49A0-A9E7-66A8033A97A6 Q34416921-87240AD3-E71E-48D3-835E-C9A2293117F9 Q34623833-7E477A2D-6412-4EF9-9069-C51C3911D889 Q34637928-E3AC1896-95C6-434D-A670-B899F1E506F5 Q34669691-7B423E30-87BA-4643-BE47-E22B94C4FDBD Q35447239-88493EF7-018F-4F43-90A1-25A425417B6F Q35547735-FC4AFFF9-0A90-48E6-8F20-57CA95DD4296 Q35588990-FD21747A-E6CC-4C14-9ECB-5850EE9A29B3 Q35740613-06F33FFE-3555-4FF1-8B32-D2F91F74FC0D Q35934151-5F5F3E1D-32AA-4BA3-9524-7479C866738D Q36051556-F032C36B-95C4-4C7A-8AED-2E308BC07102 Q36090692-6B693125-76A0-4708-B694-6DF013848C78 Q36137410-246C3C4A-28F7-47A9-9343-4E2C1614302A Q36335048-95E0530D-D691-402E-96B5-0985B513AA2B Q36663208-FCDC3CEE-8C92-4DB6-8AE0-0FE93782E2CF Q37004363-D69FBFFB-CE14-4366-98B3-3F4967016BA0 Q37097780-725B12DB-3EAA-4CE7-95D5-E0AD1D337FB1 Q37148272-C4CF4392-C379-488F-90F7-DE2176939F4C Q37149325-E77BBC59-898E-41AC-A356-CEAD8257D432 Q37235719-02F9990B-998A-45EB-955E-B7132701F851 Q37446899-8F6AFD7A-932F-4BE7-803E-4EB5C1AF0BF0 Q37722595-4575A566-03F0-441D-977C-09E61E37619E Q37982309-430A4D40-3AAB-498E-B747-FC81E5F2303C Q38022179-C405CC4F-F681-4858-8073-A51738604554 Q38231124-D85E1027-DA27-4EDB-A834-939FF1881D73 Q38809649-488CA7FD-A18A-499A-8C8B-67F482ABA6CE Q38834700-A1014A95-C1FF-48C8-8E94-41BD52115E47 Q38913876-A97640B5-7C89-4461-8AA6-B31AED1F527F Q39010202-463FDF93-EF2C-40A0-B86E-3F625ED48E45

P2860

Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia.

http://www.wikidata.org/entity/Q44236057

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Double blind randomised placeb ...... r sleep disorders in dementia.

@en

Double blind randomised placeb ...... r sleep disorders in dementia.

@nl

type

label

Double blind randomised placeb ...... r sleep disorders in dementia.

@en

Double blind randomised placeb ...... r sleep disorders in dementia.

@nl

prefLabel

Double blind randomised placeb ...... r sleep disorders in dementia.

@en

Double blind randomised placeb ...... r sleep disorders in dementia.

@nl

P1433

Q44236057-F57374D2-2F31-41D9-9B5B-B2901663B47B

P1476

Q44236057-2E90592C-C194-4720-94A8-64A299A69F10

P2093

Q44236057-397FE305-FC3C-4C8E-B439-E0E0CED8EEDD

Q44236057-44B15898-67ED-4052-9582-111C8A93C2FC

Q44236057-6441EC9D-CBD9-4B54-9D7F-10C69ACC8AE9

Q44236057-7FC1EBB7-8767-4C28-B572-2CF195E9190E

Q44236057-CD000DC0-F28B-4064-86C1-6499623F9391

P2860

Q44236057-10327C9E-3D43-46A2-B7B2-AACDCA1D84AA

Q44236057-A97DE725-4A41-421C-9057-031D8A103F66

Q44236057-CF12A9C3-4651-47CE-B9EA-5CE5942A6334

Q44236057-DAFCE1BE-2A07-4BFB-90B6-3A14F440AEDD

P304

Q44236057-D7782B4D-D3EE-446F-BF0A-E415F3DD6832

P31

Q44236057-8F553184-8D7C-4716-8123-36FDD8125C20

P356

Q44236057-52DBD189-5715-43C3-9DF6-1C8E488B794F

P407

Q44236057-69F787E1-C980-4BCD-AF44-345D0373EDA3

P433

Q44236057-E441006A-09A5-4E27-AD4C-BFA2D3E2552D

P478

Q44236057-5E7372BC-2CD2-4388-8529-CCDE1718FD43

P577

Q44236057-E8D8DC3E-C076-481F-B1D1-0E90D523BDE4

P698

Q44236057-45B26F0E-45DE-41EB-B7F6-D0ECC2318717

P921

Q44236057-31583B95-BBF3-42AA-B69B-94964C7151FB

Q44236057-426E382D-1ACB-4D99-9571-E406F5D80200

Q44236057-5B54C200-949A-40BD-9405-A041B7A9F263

P356

P1433

International Journal of Geriatric Psychiatry

P1476

Double blind randomised placeb ...... r sleep disorders in dementia.

@en

P2093

James Warner

http://www.w3.org/2001/XMLSchema#string

Marc Serfaty

http://www.w3.org/2001/XMLSchema#string

Peter Raven

http://www.w3.org/2001/XMLSchema#string

Robert Blizard

http://www.w3.org/2001/XMLSchema#string

Sandra Kennell-Webb

http://www.w3.org/2001/XMLSchema#string

P2860

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.

How to do it. Get patients' consent to enter clinical trials

A metaanalysis of controlled trials of neuroleptic treatment in dementia.

The relations among caregiver stress, "sundowning" symptoms, and cognitive decline in Alzheimer's disease.

P304

1120-1127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/GPS.760

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2002-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12461760

http://www.w3.org/2001/XMLSchema#string

P921